Willow Historical Financial Ratios
| WLLW Stock | CAD 0.08 0.01 5.88% |
Willow Biosciences is currently reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 10.07, Dividend Yield of 0.0, PTB Ratio of 3.8 or Days Sales Outstanding of 49.11 will help investors to properly organize and evaluate Willow Biosciences financial condition quickly.
Willow |
About Willow Financial Ratios Analysis
Willow BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Willow Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Willow financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Willow Biosciences history.
Willow Biosciences Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Willow Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Willow Biosciences sales, a figure that is much harder to manipulate than other Willow Biosciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most ratios from Willow Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Willow Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Willow Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Willow Biosciences' Receivables Turnover is very stable compared to the past year. As of the 4th of December 2024, Shareholders Equity Per Share is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 10.07.
| 2022 | 2023 | 2024 (projected) | Payables Turnover | 6.87 | 2.88 | 5.0 | Days Of Inventory On Hand | 13.53 | 44.06 | 46.26 |
Willow Biosciences fundamentals Correlations
Click cells to compare fundamentals
Willow Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Willow Biosciences fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 10.1K | 9.6K | 405.97 | 17.32 | 10.6 | 10.07 | |
| Ptb Ratio | 2.1 | (171.62) | 1.82 | 0.87 | 3.62 | 3.8 | |
| Book Value Per Share | 0.31 | (0.006818) | 0.25 | 0.13 | 0.0277 | 0.029 | |
| Free Cash Flow Yield | (0.34) | (0.14) | (0.37) | (1.02) | (0.93) | (0.98) | |
| Operating Cash Flow Per Share | (0.13) | (0.16) | (0.15) | (0.11) | (0.0879) | (0.0923) | |
| Stock Based Compensation To Revenue | 564.83 | 95.1 | 12.8 | 1.78 | 0.36 | 0.34 | |
| Capex To Depreciation | 3.1 | 0.31 | 0.55 | 0.26 | 0.34 | 0.32 | |
| Pb Ratio | 2.1 | (171.62) | 1.82 | 0.87 | 3.62 | 3.8 | |
| Ev To Sales | 6.0K | 8.1K | 185.54 | 4.72 | 9.76 | 9.27 | |
| Free Cash Flow Per Share | (0.7) | (0.22) | (0.17) | (0.12) | (0.0929) | (0.0975) | |
| Roic | (2.02) | 41.3 | (0.79) | (1.13) | (3.2) | (3.04) | |
| Net Income Per Share | (0.62) | (0.41) | (0.0514) | (0.12) | (0.1) | (0.11) | |
| Sales General And Administrative To Revenue | 1.8K | 641.7 | 58.55 | 10.1 | 4.78 | 4.54 | |
| Research And Ddevelopement To Revenue | 582.8 | 725.7 | 86.55 | 9.1 | 5.8 | 5.51 | |
| Capex To Revenue | 1.5K | 99.7 | 13.28 | 0.83 | 0.53 | 0.5 | |
| Pocfratio | (5.03) | (7.51) | (2.96) | (1.03) | (1.14) | (1.08) | |
| Capex To Operating Cash Flow | (0.73) | (0.078) | (0.0969) | (0.0492) | (0.0567) | (0.0595) | |
| Pfcf Ratio | (2.91) | (6.96) | (2.7) | (0.98) | (1.08) | (1.02) | |
| Income Quality | 0.21 | 0.38 | 2.97 | 0.94 | 0.84 | 0.44 | |
| Roe | (2.02) | 60.8 | (0.21) | (0.9) | (3.79) | (3.6) | |
| Ev To Operating Cash Flow | (3.02) | (6.33) | (1.35) | (0.28) | (1.05) | (0.99) | |
| Pe Ratio | (1.04) | (2.82) | (8.76) | (0.96) | (0.95) | (1.0) | |
| Return On Tangible Assets | (1.62) | (1.56) | (0.18) | (0.82) | (1.95) | (2.05) | |
| Ev To Free Cash Flow | (1.74) | (5.87) | (1.23) | (0.27) | (0.99) | (0.94) | |
| Earnings Yield | (0.97) | (0.35) | (0.11) | (1.04) | (1.05) | (1.1) | |
| Net Debt To E B I T D A | 0.42 | 0.49 | 10.04 | 0.86 | 0.0894 | 0.0849 | |
| Current Ratio | 11.24 | 10.88 | 22.21 | 9.44 | 2.3 | 2.55 | |
| Tangible Book Value Per Share | 0.22 | (0.00761) | 0.25 | 0.13 | 0.0276 | 0.029 | |
| Graham Number | 2.06 | 0.25 | 0.53 | 0.6 | 0.26 | 0.24 | |
| Shareholders Equity Per Share | 0.31 | (0.006818) | 0.25 | 0.13 | 0.0277 | 0.029 | |
| Capex Per Share | 0.0931 | 0.0122 | 0.0147 | 0.005515 | 0.004982 | 0.004733 |
Pair Trading with Willow Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Willow Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Willow Stock
Moving against Willow Stock
The ability to find closely correlated positions to Willow Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Willow Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Willow Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Willow Biosciences to buy it.
The correlation of Willow Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Willow Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Willow Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Willow Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Willow Stock
Willow BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Willow Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Willow financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Willow Biosciences history.